Skip to main content
Doris Li, MD, General Surgery, Temple, TX

DorisSophiaLiMD

General Surgery Temple, TX

Trauma Surgery & Surgical Critical Care

Physician

Are you Dr. Li?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 54 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    2401 S 31st St
    Temple, TX 76508
    Phone+1 254-724-2111

Summary

  • Dr. Doris Li, MD is a general surgeon in Temple, Texas. She is currently licensed to practice medicine in Texas, California, and New Jersey. She is affiliated with Tyler ContinueCARE Hospital and CHRISTUS Mother Frances Hospital - Tyler.

Education & Training

  • Loma Linda University Health Education Consortium
    Loma Linda University Health Education ConsortiumResidency, Surgery, 2010 - 2014
  • Rutgers Health/Robert Wood Johnson Medical School
    Rutgers Health/Robert Wood Johnson Medical SchoolResidency, Surgery, 2007 - 2009
  • Drexel University College of Medicine
    Drexel University College of MedicineClass of 2007

Certifications & Licensure

  • GU State Medical License
    GU State Medical License Active through 2025
  • TX State Medical License
    TX State Medical License 2022 - 2025
  • CA State Medical License
    CA State Medical License 2009 - 2024
  • NJ State Medical License
    NJ State Medical License 2008 - 2012
  • American Board of Surgery Surgery

Press Mentions

  • Teva and MedinCell Announce FDA Acceptance of New Drug Application for TV-46000/mdc-IRM as a Treatment for Patients with Schizophrenia
    Teva and MedinCell Announce FDA Acceptance of New Drug Application for TV-46000/mdc-IRM as a Treatment for Patients with SchizophreniaAugust 31st, 2021
  • Teva Announces Availability of ProAir® Digihaler® (Albuterol Sulfate 117 Mcg) Inhalation Powder for Patients with Asthma and COPD
    Teva Announces Availability of ProAir® Digihaler® (Albuterol Sulfate 117 Mcg) Inhalation Powder for Patients with Asthma and COPDJuly 13th, 2020
  • Teva Präsentiert Auf Dem Kongress Der Europäischen Akademie Für Neurologie Neue Daten Zur Evaluierung Der Erfahrungen Von Patienten Mit Schwer Zu Behandelnder Migräne Mit AJOVY® (Fremanezumab)
    Teva Präsentiert Auf Dem Kongress Der Europäischen Akademie Für Neurologie Neue Daten Zur Evaluierung Der Erfahrungen Von Patienten Mit Schwer Zu Behandelnder Migräne Mit AJOVY® (Fremanezumab)May 25th, 2020
  • Join now to see all